Cargando…

Abnormal Cerebrovascular Reactivity in Parkinson's Disease

Detalles Bibliográficos
Autor principal:	Prakash, Kiran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644837/ https://www.ncbi.nlm.nih.gov/pubmed/26609462 http://dx.doi.org/10.1155/2015/464052

Ejemplares similares

Abnormal Cerebrovascular Reactivity in Patients with Parkinson's Disease
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2015)

Electrocardiographic abnormalities in acute cerebrovascular events
por: Wiwanitkit, Somsri, et al.
Publicado: (2013)

Single Consultation Cerebrovascular Disease Clinic
por: Thrush, David
Publicado: (2000)

Ischemic cerebrovascular diseases in patients with COVID-19
por: El Aoud, S., et al.
Publicado: (2021)

COVID-19 and Underlying Cerebrovascular Disease: Analysis on Association
por: Sookaromdee, Pathum, et al.
Publicado: (2020)

Cerebrovascular ultrasonography: Quality control
por: Joob, Beuy, et al.
Publicado: (2013)

QT dispersion and acute cerebrovascular accident
por: Onder, Halil, et al.
Publicado: (2016)

Off pump coronary artery bypass grafting in a patient with cerebrovascular disease
por: Rawat, S K S, et al.
Publicado: (2015)

The Overview of the Second Annual Winter Seminar of Cerebrovascular Diseases in Banbuntane Hotokukai Hospital
por: Mamadaliev, Dilshod, et al.
Publicado: (2018)

Cerebrovascular Resistance: The Basis of Cerebrovascular Reactivity
por: Duffin, James, et al.
Publicado: (2018)

Electrocardiographic abnormalities in patients with cerebrovascular disease
por: Passavanti, MB, et al.
Publicado: (1998)

Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson’s disease
por: Pelizzari, Laura, et al.
Publicado: (2019)

Impact of abnormal cerebrovascular reactivity on BOLD fMRI: a preliminary investigation of moyamoya disease
por: Mazerolle, Erin L., et al.
Publicado: (2016)

The Potential Cerebrovascular Sequelae of Coronavirus Disease 19 in Alzheimer’s Disease: Coincidental or Causative?
por: Egiz, Abdullah, et al.
Publicado: (2022)

Impaired Cerebrovascular Reactivity in Huntington’s Disease
por: Chan, Suk Tak, et al.
Publicado: (2021)

Response to: effect of vasa vasorum in cerebrovascular compensation: 2 case reports
por: Li, Long, et al.
Publicado: (2021)

Characterization and prognosis of very elderly patients with anemia, cardio-cerebrovascular disease, and iron deficiency in four Portuguese hospitals
por: Rego, Rita, et al.
Publicado: (2023)

Bilateral non-bifurcating carotid arteries in a patient with recurrent cerebrovascular events
por: Palaiodimou, Lina, et al.
Publicado: (2021)

Neuropathy in Parkinson's Disease. Comment: Neuropathy in Parkinson's Disease: Risk Determinants and Impact on Quality of Life
por: Fustes, Otto J. H., et al.
Publicado: (2022)

Celiac Disease and Abnormal Liver Function Test
por: Nejad, Mohammad Rostami, et al.
Publicado: (2012)

Pleural effusion in a cancerous patient with acute cerebrovascular accident: A case study
por: Chaiyasit, Kamon, et al.
Publicado: (2013)

Pure Posterior Alien Hand Syndrome Following a Cerebrovascular Lesion: Clinicoradiological Correlates
por: Yulug, Burak, et al.
Publicado: (2016)

The critical distinction between characterisation and causation in studies of COVID-19-associated cerebrovascular pathology
por: Benger, Matthew, et al.
Publicado: (2021)

Non-Invasive Continuous Cerebrovascular Monitoring for Subacute Bedside and Outpatient Settings: An Important Advancement
por: Gomez, Alwyn, et al.
Publicado: (2021)

Fiberoptic hemodynamic spectroscopy reveals abnormal cerebrovascular reactivity in a freely moving mouse model of Alzheimer’s disease
por: Gareau, Daniel S., et al.
Publicado: (2023)

Cerebrovascular infarct associated with intracoronary adenosine: a possible rare fractional flow reserve complication
por: Keh, Yann Shan, et al.
Publicado: (2021)

Apomorphine in Parkinson's Disease—The Questions Raised
por: Dhamija, Rajinder K., et al.
Publicado: (2020)

Parkinson's disease and obstructive sleep apnea
por: Kawada, Tomoyuki
Publicado: (2021)

Gustatory Dysfunction in Patients with Parkinson’s Disease
por: Jacob, Navya J., et al.
Publicado: (2023)

Reply to: ‘Advances in imaging of brain abnormalities in neuromuscular disease’
por: Finsterer, Josef
Publicado: (2019)

Abnormal Cerebrovascular Reactivity and Functional Connectivity Caused by White Matter Hyperintensity Contribute to Cognitive Decline
por: Yang, Dan, et al.
Publicado: (2022)

Safety Interval From Increased Viscosity After COVID-19 Vaccination Among Persons With Cerebrovascular Problems
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Generalizability and effect size of the impact of anti‐hypertensive medication adherence on long‐term cardio‐cerebrovascular mortality
por: Shihora, Dhvani, et al.
Publicado: (2022)

Association of heat shock proteins with Parkinson’s disease
por: Broer, Linda, et al.
Publicado: (2011)

Cautionary optimism: caffeine and Parkinson’s disease risk
por: Sokol, Leonard L., et al.
Publicado: (2016)

Bentall Procedure in a Patient with Parkinson Disease
por: Sreedhar, Nanditha, et al.
Publicado: (2017)

Mitochondrial DNA mutations in Parkinson's disease brain
por: Simon, David K., et al.
Publicado: (2017)

Huntington’s Disease Presenting as Adult-Onset Parkinsonism
por: Kwak, In Hee, et al.
Publicado: (2022)

Treatment of Parkinson's disease in Iranian ancient medicine
por: Nobari, Hossein Jalaei, et al.
Publicado: (2023)

Parkinson's Disease: The Dirty Truth about the Air
por: Scorza, Fulvio A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_06otv3hniud5ferlb0v49givvl